X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
homozygous familial hypercholesterolemia (653) 653
humans (467) 467
index medicus (296) 296
atherosclerosis (192) 192
female (189) 189
male (188) 188
hypercholesterolemia (177) 177
animals (169) 169
cholesterol (158) 158
low-density-lipoprotein (142) 142
peripheral vascular disease (139) 139
cardiac & cardiovascular systems (129) 129
adult (120) 120
biochemistry & molecular biology (116) 116
low density lipoproteins (112) 112
familial hypercholesterolemia (109) 109
pharmacology & pharmacy (109) 109
hyperlipoproteinemia type ii - genetics (108) 108
homozygote (105) 105
middle aged (87) 87
cholesterol, ldl - blood (84) 84
coronary-heart-disease (82) 82
adolescent (77) 77
receptors, ldl - genetics (77) 77
treatment outcome (76) 76
child (75) 75
risk factors (75) 75
double-blind (73) 73
lipids (72) 72
triglyceride transfer protein (71) 71
anticholesteremic agents - therapeutic use (70) 70
hyperlipoproteinemia type ii - therapy (66) 66
hyperlipoproteinemia type ii - blood (65) 65
ldl-apheresis (64) 64
statins (64) 64
apolipoprotein-b (62) 62
cardiovascular (62) 62
mutation (62) 62
genetic aspects (61) 61
lipoproteins (59) 59
metabolism (57) 57
cardiovascular disease (55) 55
endocrinology & metabolism (54) 54
density-lipoprotein cholesterol (51) 51
hematology (51) 51
mice (50) 50
phenotype (49) 49
ldl receptor (47) 47
lomitapide (47) 47
medicine, general & internal (46) 46
child, preschool (45) 45
hyperlipoproteinemia type ii - drug therapy (45) 45
lipoprotein (45) 45
efficacy (44) 44
receptors, ldl - metabolism (44) 44
therapy (44) 44
cardiovascular-disease (43) 43
lipoproteins, ldl - metabolism (43) 43
young adult (43) 43
aged (42) 42
cholesterol - blood (42) 42
lipoprotein apheresis (41) 41
monoclonal-antibody (41) 41
placebo-controlled trial (41) 41
medicine, research & experimental (40) 40
subtilisin/kexin type 9 (40) 40
transplantation (40) 40
genetics & heredity (39) 39
hypercholesterolemia - drug therapy (39) 39
blood component removal - methods (38) 38
care and treatment (38) 38
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (38) 38
ldl cholesterol (38) 38
lipoproteins, ldl - blood (38) 38
safety (38) 38
apheresis (37) 37
cardiovascular diseases (37) 37
ldl-cholesterol (37) 37
low-density lipoprotein (37) 37
management (37) 37
medicine & public health (37) 37
cells, cultured (36) 36
cholesterol - metabolism (36) 36
health aspects (36) 36
hyperlipoproteinemia type ii - complications (36) 36
low density lipoprotein (36) 36
diagnosis (35) 35
disease (35) 35
ezetimibe (35) 35
hyperlipoproteinemia type ii - diagnosis (35) 35
analysis (34) 34
homozygous (34) 34
liver (34) 34
degradation (33) 33
lipoproteins - blood (33) 33
research (33) 33
mipomersen (32) 32
plasma (32) 32
surgery (32) 32
time factors (32) 32
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (725) 725
Spanish (15) 15
French (11) 11
German (11) 11
Russian (4) 4
Japanese (3) 3
Czech (1) 1
Portuguese (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Atherosclerosis, ISSN 0021-9150, 2012, Volume 223, Issue 2, pp. 262 - 268
Journal Article
Current pharmaceutical design, ISSN 1381-6128, 2018, Volume 24, Issue 31, pp. 3616 - 3621
Background: Familial Hypercholesterolemia (FH) is an autosomal-dominant genetic disease, associated with premature atherosclerotic Cardiovascular Disease... 
LDL apheresis | PCSK9 inhibitors | ezetimibe | LDL-C | lomitapide | Homozygous familial hypercholesterolemia | statins | liver transplantation | mipomersen | TRIGLYCERIDE TRANSFER PROTEIN | LDL-APHERESIS | YOUNG-ADULTS | LIVER-TRANSPLANTATION | MANAGEMENT | INHIBITION | PHARMACOLOGY & PHARMACY | LIPOPROTEINS | CORONARY-ARTERY-DISEASE | CARDIOVASCULAR RISK | EXPERT PANEL
Journal Article
Annals of Pediatric Cardiology, ISSN 0974-2069, 2014, Volume 7, Issue 2, pp. 107 - 117
Familial hypercholesterolemia (FH) is a genetic disorder of lipoprotein metabolism resulting in elevated serum low-density lipoprotein (LDL) cholesterol levels... 
low-density lipoprotein receptor mutation | Familial hypercholesterolemia | homozygous familial hypercholesterolemia | heterozygous familial hypercholesterolemia | Pediatric cardiology | Hypercholesterolemia | Research | Cardiovascular research | Review
Journal Article
The Nurse Practitioner, ISSN 0361-1817, 02/2019, Volume 44, Issue 2, pp. 18 - 24
If undiagnosed and untreated, familial hypercholesterolemia can lead to serious cardiac complications, such as premature atherosclerotic cardiovascular... 
xanthomas | atherosclerotic cardiovascular disease | homozygous familial hypercholesterolemia | heterozygous familial hypercholesterolemia | low-density lipoprotein cholesterol | familial hypercholesterolemia | Dosage and administration | Hypercholesterolemia | Diagnosis | Drug therapy | Risk factors | Statins
Journal Article
Atherosclerosis, ISSN 0021-9150, 06/2019, Volume 285, pp. 87 - 92
Homozygous familial hypercholesterolemia (hoFH) is a rare genetic disease, hallmarked by a lifelong exposure to very high levels of low-density lipoprotein... 
cCTA | Echocardiography | Familial hypercholesterolemia | Imaging | Homozygous | CARDIAC & CARDIOVASCULAR SYSTEMS | ATHEROSCLEROSIS | PERIPHERAL VASCULAR DISEASE | SEVERITY | CT imaging | Hypercholesterolemia | Angiography | Low density lipoproteins | Cardiac patients | Atherosclerosis | Genetic aspects | Cardiology
Journal Article
Journal Article
Atherosclerosis, ISSN 0021-9150, 2014, Volume 236, Issue 1, pp. 54 - 61
Journal Article
Journal Article
Clinical Lipidology, ISSN 1758-4299, 08/2013, Volume 8, Issue 4, pp. 407 - 409
Evaluation of: Rocha VZ, Chacra AP, Salgado W et al. Extensive xanthomata and severe subclinical atherosclerosis in homozygous familial hypercholesterolemia.... 
coronary artery disease | homozygous | microsomal transfer protein inhibitor | antisense oligonucleotide | apheresis | familial hypercholesterolemia | xanthoma | DIAGNOSIS | PROTEIN | EFFICACY | BIOCHEMISTRY & MOLECULAR BIOLOGY | ATORVASTATIN | TRIAL | LIPOPROTEIN APHERESIS
Journal Article
Journal of Atherosclerosis and Thrombosis, ISSN 1340-3478, 2017
Familial hypercholesterolemia (FH) is a disease characterized by a triad: elevated low-density lipoprotein (LDL) cholesterol, tendon xanthomas, and premature... 
Homozygous FH | Heterozygous FH | Statin | Atherosclerotic cardiovascular disease (ASCVD) | Familial hypercholesterolemia (FH)
Journal Article